The skincare product market is one of the most successful industries at monetising hope. It sells the promise of transformation through bottles and jars, at price points from accessible to extraordinary, and it has done so effectively that most people’s first response to any skin concern is to search for a product that addresses it.
The growth of in-clinic treatments represents a different understanding of what skin improvement requires. Not better products, but different tools: tools that work at depths and with mechanisms that topical application cannot reach. The shift from product-reliant skincare toward a combined approach that includes professional treatments reflects a more accurate model of how skin actually changes, and when products reach their limits.
Why Products Have Limits
Topical products work on and just beneath the skin surface. The most effective ingredients, retinoids, vitamin C, alpha hydroxy acids, and niacinamide, produce their effects by interacting with the uppermost layers of the skin: accelerating cell turnover, providing antioxidant protection, brightening surface pigmentation, improving hydration and barrier function.
These effects are real and cumulative. A well-designed topical routine maintained over years produces meaningfully better skin than no routine. But their effects are limited by how deep topical products can act. Structural changes in the dermis, the deeper layer where collagen and elastin live and where the damage of ageing, sun exposure, and injury accumulates, are outside the reach of even the most active topical formulation.
This is not a failure of the products. It’s a physical reality of how skin is structured. The collagen loss that produces fine lines and loss of firmness, the tissue damage beneath a scar, and the deep pigmentation settled into the dermis rather than the epidermis require energy, mechanical stimulation, or injection to address. Not a better serum.
The In-Clinic Treatment Landscape
In-clinic treatments cover a wide range of modalities, from relatively accessible entry-level procedures to more complex interventions that require medical oversight.
Chemical peels at clinical strengths resurface the skin more aggressively than any topical exfoliant, removing the outer layers and stimulating regeneration that improves texture, tone, and surface pigmentation. Superficial peels suit regular maintenance. Deeper peels address more significant concerns but require more recovery.
Microneedling creates controlled injury in the dermis that triggers a healing response, producing new collagen over a course of treatments. It improves skin texture, fine lines, and, given enough sessions and appropriate technique, atrophic scarring. Radiofrequency microneedling adds thermal energy to the dermis through the needle tips, producing results that exceed what mechanical needling alone achieves.
Laser treatments, from IPL for surface pigmentation to fractional ablative lasers for more significant resurfacing, address concerns at specific tissue depths with precision topical products can’t match. The right laser for a given concern produces results in a single session or a short course that years of topical treatment wouldn’t replicate.
Injectable treatments, including botulinum toxin for dynamic lines and hyaluronic acid fillers for volume restoration, address structural or muscle-driven changes rather than surface-level ones. They require skill and anatomical knowledge to produce results that look natural rather than treated.
Scar Revision: Where In-Clinic Treatment Is Most Essential
The gap between what products can do and what in-clinic treatments can achieve is widest with scarring. Scar revision sits firmly in the territory where professional treatment isn’t a premium upgrade to a topical approach: it’s the only approach with meaningful efficacy.
Atrophic scars, the pitted or depressed type most commonly from acne, represent a tissue deficit in the dermis. Topical products cannot replace missing tissue. Microneedling stimulates new collagen production in the dermis, gradually filling and smoothing these deficits over a course of treatments. Fractional laser resurfacing achieves a more aggressive version of the same outcome, with more visible results per session at the cost of greater downtime. Subcision releases the fibrous tethering that anchors the most depressed scars to the underlying tissue, allowing the skin to rise as collagen forms in the space created.
Hypertrophic and keloid scars, which involve excessive collagen production, require a different category of intervention: corticosteroid injections that suppress the overactive healing response, laser treatment that reduces redness and softens texture, and silicone therapy for ongoing collagen regulation. Surgical revision repositions or excises scar tissue when the location, orientation, or nature of the scar produces a result that other interventions can’t adequately address.
None of this is achievable through topical application, no matter how sophisticated the formulation. The biology of scarring sits below the surface, and addressing it requires tools that work below the surface.
The Integrated Approach
Framing products versus in-clinic treatments is ultimately a false dichotomy. The most effective approach to skin health and improvement combines both, with each playing the role it’s suited to.
Topical skincare forms the foundation: protecting the skin from UV damage, maintaining barrier health, supporting collagen through consistent retinoid use, and managing surface concerns that don’t require professional intervention. In-clinic treatments address concerns beneath the surface: structural changes, deeper pigmentation, and scarring that topical products can manage around but can’t resolve.
Sun protection and appropriate topical support before and after professional treatments improve both treatment outcomes and how long the improvements last. Retinoids used consistently between laser or microneedling courses extend and support the collagen remodelling that the treatment initiates. The two categories reinforce each other rather than competing.
The growing role of in-clinic treatments in beauty and skincare reflects a fuller understanding of what the skin needs at different stages and for different concerns. Products remain valuable. They just aren’t the only tool, and for some concerns they were never the right one.
You may also read: Health & Fitness.
